Consensus SanBio Company Limited OTC Markets

Equities

Market Closed - OTC Markets Other stock markets 19:09:17 09/04/2024 BST			5-day change	1st Jan Change
2.81 ^USD	-48.72%		-.--%	-.--%

03-19	SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	MT
03-19	Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform	MT

7c7ebaa3d.SBA_g3r0zLQ7Mb1m7GhRebWJgPB6PqPmOijCsncyDM8.cVEItRSThttMBY4oriYnDdbW4Z4zTc-JeH_11xRnaJ8QdlWuPsOY_FNL9A~fc0ec2bce557508b65d3d60fd11d0d12

Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform	03-19	MT
Jefferies Adjusts Sanbio’ Price Target to 310 Yen From 420 Yen, Keeps at Underperform	25/10/23	MT
Jefferies Adjusts SanBio's Price Target to 420 Yen From 550 Yen, Keeps at Underperform	28/07/23	MT
Jefferies Downgrades SanBio to Underperform From Hold, Adjusts Price Target to 550 Yen From 1,100 Yen	20/02/23	MT
Jefferies Starts SanBio at Hold With 1,100 Yen Price Target	23/01/23	MT
Rosier FY23 Economic Outlook Pulls Japanese Shares Out of Losses; Rakuten's S&P Rating Deteriorates	22/12/22	MT

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

499 JPY

Average target price

800 JPY

Spread / Average Target

+60.32%

High Price Target

2,300 JPY

Spread / Highest target

+360.92%

Low Price Target

270 JPY

Spread / Lowest Target

-45.89%

Jefferies & Co.